Yunpeng Yi

808 total citations · 1 hit paper
36 papers, 524 citations indexed

About

Yunpeng Yi is a scholar working on Small Animals, Immunology and Pharmacology. According to data from OpenAlex, Yunpeng Yi has authored 36 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Small Animals, 14 papers in Immunology and 13 papers in Pharmacology. Recurrent topics in Yunpeng Yi's work include Veterinary medicine and infectious diseases (23 papers), Pharmacological Effects of Natural Compounds (13 papers) and Toxin Mechanisms and Immunotoxins (13 papers). Yunpeng Yi is often cited by papers focused on Veterinary medicine and infectious diseases (23 papers), Pharmacological Effects of Natural Compounds (13 papers) and Toxin Mechanisms and Immunotoxins (13 papers). Yunpeng Yi collaborates with scholars based in China, France and United States. Yunpeng Yi's co-authors include Ruofeng Shang, Jianping Liang, Weiguo Shen, Jing Wang, Bo Lu, Hanxiao Sun, Ye Xiao, Chengqi Yi, Yongkang Hou and Jinying Peng and has published in prestigious journals such as Journal of the American Chemical Society, Nature Biotechnology and PLoS ONE.

In The Last Decade

Yunpeng Yi

34 papers receiving 521 citations

Hit Papers

Absolute quantification of single-base m6A methylation in... 2022 2026 2023 2024 2022 50 100 150 200

Peers

Yunpeng Yi
Yunpeng Yi
Citations per year, relative to Yunpeng Yi Yunpeng Yi (= 1×) peers Zahra Kianmehr

Countries citing papers authored by Yunpeng Yi

Since Specialization
Citations

This map shows the geographic impact of Yunpeng Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunpeng Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunpeng Yi more than expected).

Fields of papers citing papers by Yunpeng Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunpeng Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunpeng Yi. The network helps show where Yunpeng Yi may publish in the future.

Co-authorship network of co-authors of Yunpeng Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Yunpeng Yi. A scholar is included among the top collaborators of Yunpeng Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunpeng Yi. Yunpeng Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Shaodong, Haiyang Zhang, Jing Wu, et al.. (2025). Difference Analysis on Virulence Genes, Biofilms and Antimicrobial Susceptibility of Escherichia coli from Clinical and Subclinical Bovine Mastitis. Veterinary Sciences. 12(2). 132–132. 1 indexed citations
3.
Wu, Hao, Lingna Zheng, Yunpeng Yi, et al.. (2025). Zonated Copper‐Driven Breast Cancer Progression Countered by a Copper‐Depleting Nanoagent for Immune and Metabolic Reprogramming. Advanced Science. 12(20). e2412434–e2412434. 1 indexed citations
4.
Yi, Yunpeng, Jiaming Zhang, Haiting Wang, et al.. (2024). Design, synthesis, and biological evaluation of novel pleuromutilin derivatives with methicillin-resistant Staphylococcus aureus -targeting phenol linker groups. European Journal of Medicinal Chemistry. 282. 117061–117061. 4 indexed citations
5.
Lin, Shuqian, et al.. (2024). Safety and efficacy evaluation of halicin as an effective drug for inhibiting intestinal infections. Frontiers in Pharmacology. 15. 1389293–1389293. 4 indexed citations
7.
Zhang, Qiaoli, Wenbo Sun, Qingmei Li, et al.. (2024). A rapid simultaneous detection of duck hepatitis A virus 3 and novel duck reovirus based on RPA CRISPR Cas12a/Cas13a. International Journal of Biological Macromolecules. 274(Pt 1). 133246–133246. 14 indexed citations
8.
Zhang, Hongjuan, Yuhang Zhou, Yunpeng Yi, et al.. (2024). Antimicrobial activity, safety and pharmacokinetics evaluation of PMTM: A novel pleuromutilin candidate. Biomedicine & Pharmacotherapy. 179. 117378–117378. 2 indexed citations
9.
Liu, Qinqin, Hongjuan Zhang, Yunpeng Yi, et al.. (2023). Synthesis and evaluation of novel pleuromutilin derivatives targeting the 50S ribosomal subunit for antibacterial ability. European Journal of Medicinal Chemistry. 262. 115882–115882. 7 indexed citations
10.
Zhang, Hongjuan, Zhen Yang, Di Wu, et al.. (2023). The Effect of Polymer Blends on the In Vitro Release/Degradation and Pharmacokinetics of Moxidectin-Loaded PLGA Microspheres. International Journal of Molecular Sciences. 24(19). 14729–14729. 5 indexed citations
11.
Yi, Yunpeng, et al.. (2023). Novel pyridinium cationic pleuromutilin analogues overcoming bacterial multidrug resistance. European Journal of Medicinal Chemistry. 251. 115269–115269. 15 indexed citations
12.
Ji, Shengwei, Eloiza May Galon, Mohamed Abdo Rizk, et al.. (2022). Efficacy of the Antimalarial MMV390048 against Babesia Infection Reveals Phosphatidylinositol 4-Kinase as a Druggable Target for Babesiosis. Antimicrobial Agents and Chemotherapy. 66(9). e0057422–e0057422. 3 indexed citations
13.
Liu, Cong, Hanxiao Sun, Yunpeng Yi, et al.. (2022). Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI. Nature Biotechnology. 41(3). 355–366. 203 indexed citations breakdown →
14.
Zhou, Yuhang, Yunpeng Yi, Zheng Yang, et al.. (2022). Discovery of novel pleuromutilin derivatives as potent antibacterial agents. European Journal of Medicinal Chemistry. 237. 114403–114403. 12 indexed citations
15.
Yi, Yunpeng, et al.. (2020). Cytochrome P450 inhibition potential and initial genotoxic evaluation of 14-O-[(4,6-diaminopyrimidine-2-yl)thioacetyl] mutilin. Scientific Reports. 10(1). 13474–13474. 8 indexed citations
16.
Liu, Yu, Hao Wang, Tao Shi, et al.. (2020). Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation. European Journal of Medicinal Chemistry. 207. 112735–112735. 16 indexed citations
17.
Yi, Yunpeng, et al.. (2018). A new pleuromutilin candidate with potent antibacterial activity against Pasteurella multocida. Microbial Pathogenesis. 127. 202–207. 10 indexed citations
18.
Yi, Yunpeng, Ximing Xu, Yu Liu, et al.. (2016). Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety. European Journal of Medicinal Chemistry. 126. 687–695. 30 indexed citations
19.
Yi, Yunpeng, et al.. (2015). Synthesis and evaluation of novel pleuromutilin derivatives with a substituted pyrimidine moiety. European Journal of Medicinal Chemistry. 101. 179–184. 17 indexed citations
20.
Shang, Ruofeng, et al.. (2013). Chemical Synthesis and Biological Activities of Novel Pleuromutilin Derivatives with Substituted Amino Moiety. PLoS ONE. 8(12). e82595–e82595. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026